Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari "Aldo Moro", 70124 Bari, Italy.
Division of Urology, European Institute of Oncology, IRCCS, 71013 Milan, Italy.
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
The crosstalk among the complement system, immune cells, and mediators of inflammation provides an efficient mechanism to protect the organism against infections and support the repair of damaged tissues. Alterations in this complex machinery play a role in the pathogenesis of different diseases. Core complement proteins C3 and C5, their activation fragments, their receptors, and their regulators have been shown to be active intracellularly as the complosome. The kidney is particularly vulnerable to complement-induced damage, and emerging findings have revealed the role of complement system dysregulation in a wide range of kidney disorders, including glomerulopathies and ischemia-reperfusion injury during kidney transplantation. Different studies have shown that activation of the complement system is an important component of tumorigenesis and its elements have been proved to be present in the TME of various human malignancies. The role of the complement system in renal cell carcinoma (RCC) has been recently explored. Clear cell and papillary RCC upregulate most of the complement genes relative to normal kidney tissue. The aim of this narrative review is to provide novel insights into the role of complement in kidney disorders.
补体系统、免疫细胞和炎症介质的串扰提供了一种有效的机制,可保护机体免受感染并支持受损组织的修复。该复杂机制的改变在多种疾病的发病机制中起作用。核心补体蛋白 C3 和 C5、它们的激活片段、它们的受体和它们的调节剂已被证明作为复合物在细胞内发挥作用。肾脏特别容易受到补体引起的损伤,新的发现揭示了补体系统失调在广泛的肾脏疾病中的作用,包括肾小球疾病和肾移植期间的缺血再灌注损伤。不同的研究表明,补体系统的激活是肿瘤发生的重要组成部分,其成分已被证明存在于各种人类恶性肿瘤的 TME 中。补体系统在肾细胞癌 (RCC) 中的作用最近得到了探讨。透明细胞和乳头状 RCC 相对于正常肾组织上调大多数补体基因。本综述的目的是为补体在肾脏疾病中的作用提供新的见解。